Glimiprex MF Forte 1 Tablet PR is a combination oral antidiabetic medication containing Glimepiride 1 mg and Metformin 1000 mg, indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea derivative, stimulates pancreatic beta cells to enhance insulin secretion, thereby improving glycemic control. Metformin, a biguanide, primarily reduces hepatic glucose production and increases peripheral insulin sensitivity, contributing to improved glucose uptake and utilization. The combination of these agents offers complementary mechanisms of action, providing effective glycemic control in patients inadequately managed with monotherapy. Glimiprex MF Forte 1 Tablet PR is typically prescribed as part of a comprehensive diabetes management plan, including diet and exercise. It is important to monitor blood glucose levels regularly to assess therapeutic efficacy and adjust dosage accordingly. Caution is advised in patients with renal or hepatic impairment, and it is contraindicated in conditions predisposing to lactic acidosis. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, and diarrhea, as well as hypoglycemia due to the sulfonylurea component. Patient adherence and regular follow-up are essential to optimize treatment outcomes and minimize potential risks associated with therapy.

Dosage & How to Use